Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients—Analysis of...

Por Sebastian Stintzing, Boryana Ivanova, Boryana Ivanova, Ingrid Ricard, Andreas Jung, Thomas Kirchner, Andrea Tannapfel, Hendrik Juette, Susanna Hegewisch-Becker, Dirk Arnold, Anke Reinacher-Schick
Publicado em 2018-11-01

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled...

Por Thomas J. Ettrich, Andreas W. Berger, Lukas Perkhofer, Severin Daum, Alexander König, Andreas Dickhut, Uwe Wittel, Kai Wille, Michael Geissler, Hana Algül, Eike Gallmeier, Jens Atzpodien, Marko Kornmann, Rainer Muche, Nicole Prasnikar, Andrea Tannapfel, Anke Reinacher-Schick, Waldemar Uhl, Thomas Seufferlein
Publicado em 2018-12-01

Causes of mortality in elderly UICC stage III colon cancer (CC) patients––Tumor‐related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP)...

Por Stefanie Nöpel‐Dünnebacke, Hendrick Jütte, Robin Denz, Inke Sabine Feder, Anna‐Lena Kraeft, Celine Lugnier, Christian Teschendorf, Daniela Collette, Hinrich Böhner, Lars Engel, Lothar Mueller, Frank Hartmann, Ulrich Kaiser, Harald‐Robert Bruch, Stephan Hollerbach, Dirk Arnold, Nina Timmesfeld, Andrea Tannapfel, Anke Reinacher‐Schick
Publicado em 2022-04-01